Renalase: development as an innovative new drug for acute pancreatitis
Active Project Grant Awarded Last action
- Award ID
- R44DK111251
- Recipient
-
Bessor Pharma, LLC UEI GJ23WBJR8NV1
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,993,094
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date 84% complete
- Originally
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $1,099,995 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $903,732 | |
| Amendment | $903,732 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,136,337 | |
| Original award | $849,303 |
Quick answers
Who received award R44DK111251?
R44DK111251 was awarded to Bessor Pharma, LLC by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 20, 2016.
How much is award R44DK111251 worth?
$5,993,094 has been obligated on R44DK111251.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award